UNITED THERAPEUTICS Corp Quarterly Interest Expense in USD from Q1 2010 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
UNITED THERAPEUTICS Corp quarterly/annual Interest Expense history and growth rate from Q1 2010 to Q1 2024.
  • UNITED THERAPEUTICS Corp Interest Expense for the quarter ending March 31, 2024 was $13.3M, a 3.62% decline year-over-year.
  • UNITED THERAPEUTICS Corp Interest Expense for the twelve months ending March 31, 2024 was $58.8M, a 41.7% increase year-over-year.
  • UNITED THERAPEUTICS Corp annual Interest Expense for 2023 was $59.3M, a 83% increase from 2022.
  • UNITED THERAPEUTICS Corp annual Interest Expense for 2022 was $32.4M, a 74.2% increase from 2021.
  • UNITED THERAPEUTICS Corp annual Interest Expense for 2021 was $18.6M, a 20.9% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $58.8M $13.3M -$500K -3.62% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $59.3M $15.1M +$2.8M +22.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-21
Q3 2023 $56.5M $15.6M +$6.4M +69.6% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $50.1M $14.8M +$8.6M +139% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-02
Q1 2023 $41.5M $13.8M +$9.1M +194% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-01
Q4 2022 $32.4M $12.3M +$7.6M +162% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-21
Q3 2022 $24.8M $9.2M +$4.6M +100% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 $20.2M $6.2M +$1.5M +31.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 $18.7M $4.7M +$100K +2.17% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 $18.6M $4.7M -$100K -2.08% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-21
Q3 2021 $18.7M $4.6M -$300K -6.12% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 $19M $4.7M -$900K -16.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $19.9M $4.6M -$3.6M -43.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $23.5M $4.8M -$5.2M -52% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-22
Q3 2020 $28.7M $4.9M -$6.8M -58.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $35.5M $5.6M -$6.6M -54.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 $42.1M $8.2M -$2.1M -20.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $44.2M $10M +$5.7M +133% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 $38.5M $11.7M +$7.6M +185% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-28
Q2 2019 $30.9M $12.2M +$9.3M +321% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-29
Q1 2019 $21.6M $10.3M +$7.7M +296% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-29
Q4 2018 $13.9M $4.3M +$800K +22.9% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-24
Q3 2018 $13.1M $4.1M +$800K +24.2% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-30
Q2 2018 $12.3M $2.9M +$1.5M +107% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-31
Q1 2018 $10.8M $2.6M +$1.8M +225% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-01
Q4 2017 $9M $3.5M +$1.3M +59.1% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-26
Q3 2017 $7.7M $3.3M +$2.8M +560% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-31
Q2 2017 $4.9M $1.4M +$800K +133% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-01
Q1 2017 $4.1M $800K +$200K +33.3% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-02
Q4 2016 $3.9M $2.2M +$1.7M +340% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-27
Q3 2016 $2.2M $500K -$300K -37.5% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-25
Q2 2016 $2.5M $600K -$700K -53.8% Apr 1, 2016 Jun 30, 2016 10-Q 2017-07-27
Q1 2016 $3.2M $600K -$1.5M -71.4% Jan 1, 2016 Mar 31, 2016 10-Q 2017-04-26
Q4 2015 $4.7M $500K -$3.04M -85.9% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-21
Q3 2015 $7.74M $800K -$3.91M -83% Jul 1, 2015 Sep 30, 2015 10-Q 2016-10-27
Q2 2015 $11.6M $1.3M -$3.45M -72.6% Apr 1, 2015 Jun 30, 2015 10-Q 2016-07-28
Q1 2015 $15.1M $2.1M -$2.51M -54.4% Jan 1, 2015 Mar 31, 2015 10-Q 2016-04-28
Q4 2014 $17.6M $3.54M -$1.03M -22.5% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-22
Q3 2014 $18.6M $4.71M +$169K +3.72% Jul 1, 2014 Sep 30, 2014 10-Q 2015-10-27
Q2 2014 $18.5M $4.75M +$226K +5% Apr 1, 2014 Jun 30, 2014 10-Q 2015-07-28
Q1 2014 $18.2M $4.61M +$174K +3.92% Jan 1, 2014 Mar 31, 2014 10-Q 2015-04-28
Q4 2013 $18.1M $4.56M +$72K +1.6% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-25
Q3 2013 $18M $4.54M +$156K +3.56% Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-28
Q2 2013 $17.8M $4.52M +$641K +16.5% Apr 1, 2013 Jun 30, 2013 10-Q 2014-07-29
Q1 2013 $17.2M $4.44M +$550K +14.2% Jan 1, 2013 Mar 31, 2013 10-Q 2014-04-29
Q4 2012 $16.6M $4.49M -$620K -12.1% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-24
Q3 2012 $17.3M $4.38M -$1.03M -19.1% Jul 1, 2012 Sep 30, 2012 10-Q 2013-10-29
Q2 2012 $18.3M $3.88M -$1.55M -28.6% Apr 1, 2012 Jun 30, 2012 10-Q 2013-07-25
Q1 2012 $19.8M $3.89M -$1.52M -28.2% Jan 1, 2012 Mar 31, 2012 10-Q 2013-04-25
Q4 2011 $21.4M $5.11M -$345K -6.32% Oct 1, 2011 Dec 31, 2011 10-K 2014-02-25
Q3 2011 $21.7M $5.42M +$607K +12.6% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-01
Q2 2011 $21.1M $5.43M +$672K +14.1% Apr 1, 2011 Jun 30, 2011 10-Q 2012-07-26
Q1 2011 $20.4M $5.41M +$723K +15.4% Jan 1, 2011 Mar 31, 2011 10-Q 2012-04-26
Q4 2010 $19.7M $5.46M Oct 1, 2010 Dec 31, 2010 10-K 2013-02-26
Q3 2010 $4.81M Jul 1, 2010 Sep 30, 2010 10-Q 2011-10-27
Q2 2010 $4.76M Apr 1, 2010 Jun 30, 2010 10-Q 2011-07-28
Q1 2010 $4.69M Jan 1, 2010 Mar 31, 2010 10-Q 2011-04-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.